本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Theravance Biopharma Inc.

10.37
-0.0200-0.19%
盤後10.370.00000.00%17:13 EDT
成交量:23.60萬
成交額:244.17萬
市值:5.19億
市盈率:-8.98
高:10.55
開:10.39
低:10.15
收:10.39
資料載入中...
2022/07/14

重要事件披露

8-K - Current report
2022/07/13

重要事件披露

8-K - Current report
2022/06/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

重要事件披露

8-K - Current report
2022/04/28

重要事件披露

8-K - Current report
2022/04/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/04

重要事件披露

8-K - Current report
2022/03/04

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/28

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/23

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/10

重要事件披露

8-K - Current report
2021/12/22

重要事件披露

8-K - Current report
2021/12/16

重要事件披露

8-K - Current report